Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis.
April W ArmstrongSang Hee ParkVardhaman PatelMalcolm HoganWei-Jhih WangDavid DavidsonViktor V ChirikovPublished in: Dermatology and therapy (2023)